Regulatory role for the profilaggrin N-terminal domain in epidermal homeostasis

Journal of Investigative Dermatology

Volumn 132, Issue 10, 2012, Pages 2376-2385

  Aho, Sirpa ^a   Harding, Clive R ^a   Lee, Jian Ming ^a   Meldrum, Helen ^a   Bosko, Carol A ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 14; CYTOKERATIN 10; LENTIVIRUS VECTOR; LORICRIN; PROFILAGGRIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPIDERMIS; FIBROBLAST; HUMAN; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84866427480     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.174     Document Type: Article

References (46)

1. Broome AM, Ryan D, Eckert RL (2003) S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 51:675-85 (Pubitemid 36520623)
2. Brown SJ, Kroboth K, Sandilands A et al. (2012) Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol 132:98-104
3. Brown SJ, McLean WH (2012) One remarkable molecule: filaggrin. J Invest Dermatol 132:751-62
4. Bullough WS (1973) The epidermal chalone mechanism. Natl Cancer Inst Monogr 38:99-107
5. Bullough WS (1975) Chalone control mechanisms. Life Sci 16:323-30
6. Celli A, Mackenzie DS, Crumrine DS et al. (2011) Endoplasmic reticulum Ca2+ depletion activates XBP1 and controls terminal differentiation in keratinocytes and epidermis. Br J Dermatol 164:16-25
7. Denecker G, Hoste E, Gilbert B et al. (2007) Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 9: 666-74 (Pubitemid 47214729)
8. Elgjo K (1972) Chalone inhibition of cellular proliferation. J Invest Dermatol 59:81-3
9. Elgjo K, Clausen OP (1983) Proliferation-dependent effect of skin extracts (chalone) on mouse epidermal cell flux at the G1-S, S-G2 and G2-M transitions. Virchows Arch B Cell Pathol Incl Mol Pathol 42:143-51 (Pubitemid 13157324)
10. Fallon PG, Sasaki T, Sandilands A et al. (2009) A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41:602-8
11. Ghazizadeh S, Katz AB, Harrington R et al. (2004) Lentivirus-mediated gene transfer to human epidermis. J Investig Dermatol Symp Proc 9:269-75 (Pubitemid 39108131)
12. Ginger RS, Blachford S, Rowland J et al. (2005) Filaggrin repeat number polymorphism is associated with a dry skin phenotype. Arch Dermatol Res 297:235-41 (Pubitemid 41712809)
13. Hoste E, Kemperman P, Devos M et al. (2011) Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol 131:2233-41
14. Huffmeier U, Traupe H, Oji V et al. (2007) Loss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patients. J Invest Dermatol 127:1367-70 (Pubitemid 46762981)
15. Iizuka H (1994) Epidermal turnover time. J Dermatol Sci 8:215-7 (Pubitemid 24353989)
16. Ishida-Yamamoto A, Takahashi H, Presland RB et al. (1998) Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab Invest 78: 1245-53 (Pubitemid 28491698)
17. Kezic S, O'regan GM, Lutter R et al. (2012) Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol 129:1031-9
18. Leyvraz C, Charles RP, Rubera I et al. (2005) The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 170:487-96 (Pubitemid 41126947)
19. List K, Szabo R, Wertz PW et al. (2003) Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 163:901-10 (Pubitemid 37517896)
20. Marenholz I, Heizmann CW, Fritz G (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322:1111-22 (Pubitemid 39164640)
21. Margulis A, Zhang W, Garlick JA (2005) In vitro fabrication of engineered human skin. Methods Mol Biol 289:61-70
22. Markova NG, Marekov LN, Chipev CC et al. (1993) Profilaggrin is a major epidermal calcium-binding protein. Mol Cell Biol 13:613-25 (Pubitemid 23006938)
23. Mildner M, Jin J, Eckhart L et al. (2010) Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol 130:2286-94
24. Nirunsuksiri W, Presland RB, Brumbaugh SG et al. (1995) Decreased profilaggrin expression in ichthyosis vulgaris is a result of selectively impaired posttranscriptional control. J Biol Chem 270:871-6
25. Paladini RD, Takahashi K, Bravo NS et al. (1996) Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol 132:381-97 (Pubitemid 26052572)
26. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. (2006) Common loss-offunction variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-6
27. Pearton DJ, Dale BA, Presland RB (2002) Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J Invest Dermatol 119:661-9
28. Pearton DJ, Nirunsuksiri W, Rehemtulla A et al. (2001) Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates. Exp Dermatol 10:193-203 (Pubitemid 32492482)
29. Presland RB, Bassuk JA, Kimball JR et al. (1995) Characterization of two distinct calcium-binding sites in the amino-terminus of human profilaggrin. J Invest Dermatol 104:218-23
30. Presland RB, Boggess D, Lewis SP et al. (2000) Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 115: 1072-81 (Pubitemid 32037453)
31. Presland RB, Haydock PV, Fleckman P et al. (1992) Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem 267:23772-81 (Pubitemid 23088185)
32. Presland RB, Kimball JR, Kautsky MB et al. (1997) Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation. J Invest Dermatol 108:170-8 (Pubitemid 27061028)
33. Presland RB, Kuechle MK, Lewis SP et al. (2001) Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest. Exp Cell Res 270:199-213 (Pubitemid 33030159)
34. Richter KH, Clauss M, Hofle W et al. (1988) The epidermal G1-chalone: an endogenous tissue-specific inhibitor of epidermal cell proliferation. Ann N Y Acad Sci 548:204-10
35. Sandilands A, O'regan GM, Liao H et al. (2006) Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 126:1770-5 (Pubitemid 44086511)
36. Sandilands A, Terron-Kwiatkowski A, Hull PR et al. (2007) Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39:650-4 (Pubitemid 46676107)
37. Scott IR (1986) Alterations in the metabolism of filaggrin in the skin after chemical-and ultraviolet-induced erythema. J Invest Dermatol 87: 460-5 (Pubitemid 16027116)
38. Smith FJ, Irvine AD, Terron-Kwiatkowski A et al. (2006) Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38:337-42
39. Takaishi M, Makino T, Morohashi M et al. (2005) Identification of human hornerin and its expression in regenerating and psoriatic skin. J Biol Chem 280:4696-703 (Pubitemid 40288639)
40. Tiegel A, Richter KH, Marks F (1989) Cell cycle specificity and reversibility of the inhibitory effect of epidermal G1-chalone on DNA synthesis in partially synchronized RTE-2 keratinocytes in vitro. Exp Cell Res 182: 297-306 (Pubitemid 19154051)
41. Wood LC, Jackson SM, Elias PM et al. (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-7
42. Wu Z, Hansmann B, Meyer-Hoffert U et al. (2009) Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family. PLoS One 4:e5227
43. Yoneda K, Nakagawa T, Lawrence OT et al. (2012) Interaction of the profilaggrin N-terminal domain with loricrin in human cultured keratinocytes and epidermis. J Invest Dermatol 132:1206-14
44. Zhang D, Karunaratne S, Kessler M et al. (2002) Characterization of mouse profilaggrin: evidence for nuclear engulfment and translocation of the profilaggrin B-domain during epidermal differentiation. J Invest Dermatol 119:905-12 (Pubitemid 35340917)
45. Zhao Y, Terron-Kwiatkowski A, Liao H et al. (2007) Filaggrin null alleles are not associated with psoriasis. J Invest Dermatol 127:1878-82 (Pubitemid 47075371)
46. Zufferey R, Donello JE, Trono D et al. (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886-92 (Pubitemid 29135675)